• Home 
• Stocks 
• ETFs 
•  Funds 
•  News 
•  IPOs 
•  Markets 
•  Market Movers 
•  Rates 
•  Futures 
•  Forex 
•  Calendars 
•  Tags 

Get Quote

Advanced Lookup

 

Unigene Laboratories Inc. (UGNE) Stock Quote

•  
• Quote | 
• Profile | 
• Shares | 
• Ratios | 
• Depth/LII | 
• Options | 
• Charts | 
• News | 
• Financials  

•  
• Insiders | 
• Filings | 
• Analyst | 
• Earnings | 
• Historical | 
• Tags | 
• Updates | 
• Stock Web  

Detailed Quote for Unigene Laboratories Inc. (UGNE)  $ 0.60   0.05 (+9.09%) Volume: 71.3 k 2:38 PM EST Feb 10, 2012 close 52 Week Information 52 Week High March 28, 2011 Close: 1.42 52 Week Low December 16, 2011 Close: 0.37 Today 5d 1m 3m 1y more Last Price 0.60 Change $ 0.05 Change % 9.09% Tick N/A Bid 0.45 Bid Size 5,000 Ask 0.80 Ask Size 2,500 Open 0.595 High 0.625 Low 0.595 Prev Close 0.55 Last Trade 2/10/12 Volume 71.3 k 52 Wk Hi 1.42 52 Wk Low 0.37 Market Cap 56.83 m Ex-Div Date N/A Div Rate N/A Yield N/A Shares 94,715,599 EPS (TTM) -0.28 PE Ratio N/A close Exchange Information Listed On OTC Bulletin Board Consolidated (OTCBB) Exchange OTCBB

News and Media for Unigene Laboratories Inc.  (UGNE)  Sector News | Topic News Sector News Basic Materials   - Chemicals   - Energy   - Metals & Mining Conglomerates   - Conglomerates Consumer Goods   - Consumer Durables   - Consumer Non-Durables   - Automotive   - Food & Beverage   - Tobacco Financial   - Banking   - Financial Services   - Insurance   - Real Estate Healthcare   - Drugs   - Health Services Industrial Goods   - Aerospace/Defense   - Manufacturing   - Materials & Construction Services   - Leisure   - Media   - Retail   - Specialty Retail   - Wholesale   - Diversified Services   - Transportation Technology   - Computer Hardware   - Computer Software & Services   - Electronics   - Telecommunications   - Internet Utilities   - Utilities Hide Market News AMEX Nasdaq NYSE OTCBB Pink Sheets Mutual Funds Commodities TSX World Market News Asia Pacific Europe Corporate Actions Stock Buyback Dividends Earnings Stock Splits Insider Trading IPO's Business & Finance Antitrust Banking & Finance Capital Gains Mergers & Acquisitions Economy Consumer Price Index Bond/Stock Update Federal Reserve Foreign Exchange International Monetary Fund Interest Rates Hide News for UGNE Wed, Feb 08, 2012 9:51 AM Unigene Announces Key Appointments as Biotechnologies Strategic Business Unit Continues to Grow in 2012 - PR Newswire Tue, Feb 07, 2012 8:33 AM Unigene to Present at the 14th Annual BIO CEO & Investor Conference on February 13, 2012 - PR Newswire Wed, Feb 01, 2012 9:51 AM Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award - PR Newswire Wed, Jan 11, 2012 8:31 AM Unigene Laboratories Granted US Patent for Peptide-Based Technology for Treatment of Obesity - PR Newswire Mon, Jan 09, 2012 8:31 AM Unigene Provides 2012 Business Outlook - PR Newswire Wed, Jan 04, 2012 8:01 AM Unigene to Present at Biotech Showcase(tm) 2012 in San Francisco on January 9 - PR Newswire Mon, Dec 19, 2011 8:31 AM Unigene's 2011 Year in Review - Key Elements in Place to Address Debt in 2012 - PR Newswire Wed, Dec 07, 2011 8:02 AM Unigene to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011 - PR Newswire Mon, Dec 05, 2011 8:02 AM Unigene Regains Exclusive Worldwide Rights of Oral PTH from GSK - PR Newswire Wed, Nov 30, 2011 8:02 AM Unigene's Proprietary Peptelligence(tm) Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist - PR Newswire Wed, Nov 16, 2011 7:03 AM Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. - PR Newswire Mon, Nov 14, 2011 6:12 AM Unigene Announces Novartis' Disclosure of First Interpretable Results from Phase 3 Trial of Calcitonin (SMC021) in the Treatment of Post-menopausal Osteoporosis - Business Wire Thu, Nov 10, 2011 8:10 AM Unigene to Present at the Lazard Capital Markets 8th Annual Healthcare Conference on November 16, 2011 - PR Newswire Wed, Nov 09, 2011 8:10 AM Unigene Announces Positive Top-Line Results of Phase 2 Oral PTH Study for the Treatment of Osteoporosis in Postmenopausal Women - PR Newswire 8:01 AM Unigene Reports Third Quarter 2011 Financial Results - PR Newswire Mon, Nov 07, 2011 8:02 AM Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011 - PR Newswire Fri, Dec 11, 2009 4:57 PM AllPennyStocks.com Announces December 14th to December 18th U.S. Penny Stocks 2 Watch (CHCG.OB, UGNE.OB) - Accesswire More News for UGNE >>

Tags for Unigene Laboratories Inc.

Research stocks or mutual funds related to Unigene Laboratories Inc. by keywords or tags. Find companies that have a similar focus to UGNE. The keywords below have been associated to UGNE by either user submission or electronic means.

email stock quotes stock trading end of day stock quotes investor relations company real time stock quote osteoporosis doctor stock investments osteoporosis prevention and treatment biotech conference ups stock quote online stock quote niche pharmaceutical financial results investment products calcium osteoporosis stock information live stock quote india stock quotes financial annual report msft stock quote financial statements annual report stock investment preventing osteoporosis japan stock quotes calcium for osteoporosis after hours stock quotes financial news analysis osteoporosis in women stock quote osteoporosis treatment pharmaceutical software effects of osteoporosis old stock quotes best stocks dfc stock quote stock alerts women osteoporosis financial report warrick pharmaceutical stock ticker symbol stock quote chart osteoporosis bone loss new osteoporosis treatment licensed products calcium and osteoporosis information on osteoporosis annual report printing investor relations data xom stock quote

 

 

Home | About Us | Contact | Terms of Service | Privacy Policy | Blog

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.